首页> 外文期刊>Gastrointestinal Endoscopy >EMR of large, sessile, sporadic nonampullary duodenal adenomas: technical aspects and long-term outcome (with videos).
【24h】

EMR of large, sessile, sporadic nonampullary duodenal adenomas: technical aspects and long-term outcome (with videos).

机译:大型,无柄,散发性非壶腹十二指肠腺瘤的EMR:技术方面和长期结果(带视频)。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: EMR is a viable alternative to surgery for removal of large mucosal neoplastic lesions of the entire GI tract. Few studies have, however, been published on the safety, efficacy, and technical aspects of EMR in the duodenum. OBJECTIVE: Our purpose was to evaluate the efficacy and safety of EMR of large (>15 mm) duodenal adenomas. DESIGN: Retrospective evaluation of a defined patient cohort. SETTING: Tertiary academic referral center. PATIENTS: Patients with large (>15 mm) sporadic nonampullary duodenal adenomas managed by a standardized technique who were referred by other specialist endoscopists for endoscopic treatment. METHODS: Five-year data from patients undergoing EMR for large duodenal adenomas were reviewed retrospectively. Immediate and delayed complications were recorded. RESULTS: Twenty-one lesions were removed by EMR in 23 patients (mean age 62.2 years, 13 female, 10 male). The mean size of lesions resected was 27.6 mm (median 20 mm, range 15-60 mm). Post-EMR histologic examination revealed mucosal adenocarcinoma in 1, low-grade tubulovillous adenoma (TVA) in 16, high- or focal high-grade TVA in 3 patients, and 1 with both high-grade TVA and carcinoid. EMR was performed successfully in 18 patients during a single session. Two patients required 2 sessions and 1 required 3 sessions for complete resection. The median follow-up was 13 months (range 4-44 months). During follow-up, 5 patients had minor residual adenomas that were treated successfully with snare resection and/or argon plasma coagulation. One patient had EMR site bleeding. There were no perforations. LIMITATION: Retrospective study. CONCLUSION: EMR for large sporadic nonampullary duodenal adenomas is a safe and effective technique.
机译:背景:EMR是去除整个胃肠道大的粘膜肿瘤病变的手术的可行替代方法。然而,很少有关于十二指肠内EMR的安全性,功效和技术方面的研究发表。目的:我们的目的是评估大型(> 15 mm)十二指肠腺瘤EMR的疗效和安全性。设计:对确定的患者队列进行回顾性评估。地点:大学学术转诊中心。患者:患有散发性大(> 15毫米)的非壶腹十二指肠腺瘤,通过标准化技术治疗,并由其他专业内镜医师转诊接受内镜治疗。方法:回顾性回顾了接受EMR的十二指肠大腺瘤患者的五年数据。记录立即和延迟并发症。结果:23例患者(平均年龄62.2岁,女性13例,男性10例)通过EMR切除了21个病变。切除病变的平均大小为27.6毫米(中值20毫米,范围15-60毫米)。 EMR后的组织学检查显示1例黏膜腺癌,16例低度肾小管性腺瘤(TVA),3例高或局灶性高度TVA以及1例既有高度TVA又有类癌。在一个疗程中成功对18例患者进行了EMR。两名患者需要2个疗程,而1个患者需要3个疗程才能完全切除。中位随访时间为13个月(范围4-44个月)。在随访期间,有5例残留少量腺瘤的患者已通过圈套切除术和/或氩气血浆凝结术成功治疗。 1例患者出现EMR部位出血。没有穿孔。局限性:回顾性研究。结论:EMR治疗散发性非壶腹十二指肠腺瘤是一种安全有效的技术。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号